WSJ -- In a court ruling likely to be followed closely by the medical industry, a federal judge in Manhattan on Monday struck down some of a company’s patents on two genes linked to breast and ovarian cancers.
WSJ -- In a court ruling likely to be followed closely by the medical industry, a federal judge in Manhattan on Monday struck down some of a company’s patents on two genes linked to breast and ovarian cancers.
